TB-500 pour la réparation des tendons et ligaments : ce que la recherche démontre
Novo Pharma Research Team
Recherche Novo Pharma · synthèse de littérature révisée par les pairs
TB-500 pour la réparation des tendons et ligaments : ce que la recherche démontre
Meta Description : Le TB-500 (Thymosine Bêta-4) favorise la guérison des tendons et ligaments par la migration cellulaire, l'angiogenèse et la réduction de l'inflammation. Découvrez le protocole de charge (2-2,5 mg 2x/semaine), la méthode d'injection et le calendrier de récupération.
Keywords : TB-500 peptide, TB-500 réparation tendons, thymosine bêta 4, TB-500 guérison, TB-500 dosage
Références :
- Goldstein AL, et al. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429. PMID: 16099219
- Philp D, et al. Thymosin beta 4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev. 2004;125(2):113-115. PMID: 15037011
- Smart N, et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature. 2007;445(7124):177-182. PMID: 17108969
- Sosne G, et al. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res. 2002;74(2):293-299. PMID: 11950239
- Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. PMID: 10469334
- Ehrlich HP, Bhagavan NV. The effect of thymosin beta-4 on cell composition and collagen in carrageenan-induced granuloma pouches. Proc Soc Exp Biol Med. 1991;196(3):300-304. PMID: 1998007
- Dowling BA, et al. Recombinant equine growth hormone does not affect biomechanical properties of the superficial digital flexor tendon in standardbred horses in training. Vet Surg. 2002;31(1):61-66. PMID: 11778169
- Ruff D, et al. Thymosin Beta-4 for the treatment of non-healing venous stasis ulcers: results of a Phase II study. J Invest Dermatol. 2010;130:S82.
- Treadwell T, et al. The regenerative properties of thymosin β4 in the treatment of sports injuries and wound care. Expert Opin Biol Ther. 2018;18(sup1):131-138. PMID: 30063872
- Kleinman HK, Sosne G. Thymosin beta 4 and the potential for use in cancer therapy. Ann N Y Acad Sci. 2016;1374(1):96-102. PMID: 27333077
Cet article est publié à des fins éducatives uniquement et ne constitue pas un avis médical. Consultez un professionnel de la santé avant d'utiliser tout composé de recherche.
All compounds discussed and sold through Novo Pharma are intended strictly for laboratory and in-vitro research purposes. Products are not for human or animal consumption, not for use in food, cosmetics, or medicinal applications, and not for any therapeutic or diagnostic use.
The information on this page is provided for educational context and documents findings from published research. It is not medical advice, not a recommendation, and not a suggestion that any compound be used outside of a controlled research environment. Consult a qualified healthcare professional for any medical or health-related decision.
By purchasing, you confirm you are a qualified researcher, accept full responsibility for proper handling and disposal, and agree to use compounds in compliance with all applicable local, provincial, and federal laws.